市場調查報告書

多血小板血漿 (PRP) 市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Platelet Rich Plasma Market, By Type, By Origin, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 968768
出版日期 內容資訊 英文 184 Pages
商品交期: 2-3個工作天內
價格
多血小板血漿 (PRP) 市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Platelet Rich Plasma Market, By Type, By Origin, By Application, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年10月07日內容資訊: 英文 184 Pages
簡介

多血小板血漿 (PRP) 是類似血液的血漿分餾的一部分,並且含有高於正常血小板濃度的血漿。自2009年以來,多血小板血漿(PRP)治療的使用已顯著增加,這是由於其用途廣泛且沒有副作用。

本報告提供全球多血小板血漿 (PRP) 市場相關調查分析,提供市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態·規定·趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的發展
  • 法規方案
  • PEST分析
  • COVID-19的影響分析

第4章 全球多血小板血漿 (PRP) 市場:各類型

  • 簡介
  • Pure PRP
  • Leukocyte rich PRP
  • Pure PRF
  • Leukocyte rich PRF

第5章 全球多血小板血漿 (PRP) 市場:各來源

  • 簡介
  • 自體
  • 同種異體
  • 同類

第6章 全球多血小板血漿 (PRP) 市場:各用途

  • 簡介
  • 腦神經外科
  • 美容整形
  • 整形外科
  • 一般外科
  • 其他

第7章 全球多血小板血漿 (PRP) 市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第8章 競爭情形

  • 企業簡介
    • Arthrex, Inc.
    • Stryker Corporation
    • Johnson and Johnsons Ltd.
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab SA
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.

第9章 章節

目錄

Title:
Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, Leukocyte rich PRF), By Origin (Autologous, Allogenic, Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its wide application and no side effects. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments. Use of PRP therapy on patients with low back pain helps them to recover. It is also widely used for the treatment for baldness, as PRP treatment increase the blood flow. In turn supporting the hair growth.

Restraints of the Global Platelet Rich Plasma Market

Major factors hampering the growth of the platelet rich plasma market during the forecast period constitutes of uncertainty about therapeutic efficacy of platelet-rich plasma.

Key features of the study:

  • This report provides in-depth analysis of the global platelet rich plasma market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global platelet rich plasma market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Platelet Rich Plasma Market, By Type:
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • Global Platelet Rich Plasma Market, By Origin:
    • Autologous
    • Allogenic
    • Homologues
  • Global Platelet Rich Plasma Market, By Application:
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • Global Platelet Rich Plasma Market, By Geography:
    • North America
  • By Type
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin
    • Autologous
    • Allogenic
    • Homologues
  • By Application
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Type
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin
    • Autologous
    • Allogenic
    • Homologues
  • By Application
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Type
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin
    • Autologous
    • Allogenic
    • Homologues
  • By Application
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Type
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin
    • Autologous
    • Allogenic
    • Homologues
  • By Application
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Type
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin
    • Autologous
    • Allogenic
    • Homologues
  • By Application
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Type
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin
    • Autologous
    • Allogenic
    • Homologues
  • By Application
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Arthrex, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Stryker Corporation
    • Johnson and Johnsons Ltd.
    • Zimmer Biomet Holdings Inc.
    • Terumo Corporation
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab S.A.
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Origin
  • Market Snippet, By Application
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis

4. Global Platelet Rich Plasma Market, By Type, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Pure PRP
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Leukocyte rich PRP
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Pure PRF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Leukocyte rich PRF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Platelet Rich Plasma Market, By Origin, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Autologous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Allogenic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Homologues
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Platelet Rich Plasma Market, By Application, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Neurosurgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Cosmetic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Orthopedic Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • General Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Platelet Rich Plasma Market, By Regions, 2016 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Company Profiles
  • Arthrex, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stryker Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson and Johnsons Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zimmer Biomet Holdings Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Glofinn Oy
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medira Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Regen Lab S.A
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies.
  • CollPlant
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Generex Biotechnology Corporation
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Estar Technologies Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact